This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John L. Sever, MD

Arch Otolaryngol. 1973;98(4):265-268.

Abstract
Effective rubella vaccines that have thus far been developed contain live attenuated strains of rubella virus. The two rubella vaccines that have been licensed and are available in the United States (HPV-77 and Cendehill) meet the criteria established for an ideal vaccine.

Author Affiliations
Bethesda, Md

From the Infectious Diseases Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda.

Footnotes
Accepted for publication Jan 4, 1973.

Reprint requests to Perinatal Research Laboratory, National Institutes of Health, Bethesda, MD 20014 (Dr. Sever).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?